481 related articles for article (PubMed ID: 9526038)
1. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
Fujita K; Yamauchi M; Matsui T; Titani K; Takahashi H; Kato T; Isomura G; Ando M; Nagata Y
Brain Res; 1998 Feb; 785(1):31-40. PubMed ID: 9526038
[TBL] [Abstract][Full Text] [Related]
2. Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis.
Fujita K; Kato T; Yamauchi M; Ando M; Honda M; Nagata Y
Neurochem Res; 1998 Feb; 23(2):169-74. PubMed ID: 9475511
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical changes in the spinal cord in degenerative motor neuron diseases.
Nagata Y; Fujita K; Yamauchi M; Kato T; Ando M; Honda M
Mol Chem Neuropathol; 1998 Apr; 33(3):237-47. PubMed ID: 9642676
[TBL] [Abstract][Full Text] [Related]
4. Glial activation and TNFR-I upregulation precedes motor dysfunction in the spinal cord of mnd mice.
Mennini T; Bigini P; Cagnotto A; Carvelli L; Di Nunno P; Fumagalli E; Tortarolo M; Buurman WA; Ghezzi P; Bendotti C
Cytokine; 2004 Feb; 25(3):127-35. PubMed ID: 14698139
[TBL] [Abstract][Full Text] [Related]
5. Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development.
Fujita K; Shibayama K; Yamauchi M; Kato T; Ando M; Takahashi H; Iritani K; Yoshimoto N; Nagata Y
Neurochem Res; 1998 Apr; 23(4):557-62. PubMed ID: 9566592
[TBL] [Abstract][Full Text] [Related]
6. The 21-aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice.
Gonzalez Deniselle MC; Gonzalez SL; Piroli GG; Lima AE; De Nicola AF
Cell Mol Neurobiol; 1996 Feb; 16(1):61-72. PubMed ID: 8714560
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin.
Festoff BW; D'Andrea MR; Citron BA; Salcedo RM; Smirnova IV; Andrade-Gordon P
Mol Med; 2000 May; 6(5):410-29. PubMed ID: 10952021
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
9. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis.
Sasaki S; Komori T; Iwata M
Acta Neuropathol; 2000 Aug; 100(2):138-44. PubMed ID: 10963360
[TBL] [Abstract][Full Text] [Related]
10. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells.
Keller AF; Gravel M; Kriz J
Glia; 2009 Aug; 57(10):1130-42. PubMed ID: 19115383
[TBL] [Abstract][Full Text] [Related]
11. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic inclusions in spinal neurons of the motor neuron degeneration (Mnd) mouse. I. Light microscopic analysis.
Mazurkiewicz JE; Callahan LM; Swash M; Martin JE; Messer A
J Neurol Sci; 1993 May; 116(1):59-66. PubMed ID: 8389815
[TBL] [Abstract][Full Text] [Related]
13. Glial reaction in the spinal cord of the degenerating muscle mouse (Scn8a (dmu)).
Sato T; Fujita M; Shimizu Y; Kanetaka H; Chu LW; Côté PD; Ichikawa H
Neurochem Res; 2015 Jan; 40(1):124-9. PubMed ID: 25380697
[TBL] [Abstract][Full Text] [Related]
14. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
15. Glutamate transporters in the spinal cord of the wobbler mouse.
Bigini P; Bastone A; Mennini T
Neuroreport; 2001 Jul; 12(9):1815-20. PubMed ID: 11435904
[TBL] [Abstract][Full Text] [Related]
16. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study.
Stephens B; Guiloff RJ; Navarrete R; Newman P; Nikhar N; Lewis P
J Neurol Sci; 2006 May; 244(1-2):41-58. PubMed ID: 16487542
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin deposits are present in spinal motor neurons in all stages of the disease in the motor neuron degeneration (Mnd) mutant of the mouse.
Mazurkiewicz JE
Neurosci Lett; 1991 Jul; 128(2):182-6. PubMed ID: 1658691
[TBL] [Abstract][Full Text] [Related]
18. Modulation of HSP25 expression during anterior horn motor neuron degeneration in the paralysé mouse mutant.
Pieri I; Cifuentes-Diaz C; Oudinet JP; Blondet B; Rieger F; Gonin S; Arrigo AP; Thomas Y
J Neurosci Res; 2001 Aug; 65(3):247-53. PubMed ID: 11494359
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.
Miyagishi H; Kosuge Y; Takano A; Endo M; Nango H; Yamagata-Murayama S; Hirose D; Kano R; Tanaka Y; Ishige K; Ito Y
Cell Mol Neurobiol; 2017 Apr; 37(3):445-452. PubMed ID: 27140190
[TBL] [Abstract][Full Text] [Related]
20. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
